trending Market Intelligence /marketintelligence/en/news-insights/trending/kgiuomra0uo51cxmfekd6q2 content esgSubNav
In This List

SIGA Technologies to relist on Nasdaq

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


SIGA Technologies to relist on Nasdaq

New York-based SIGA Technologies, Inc. said it will relist on the Nasdaq Global Market on March 22.

The company's stock will trade under the SIGA ticker symbol.

SIGA Technologies is the developer of oral Tpoxx, also known as tecovirimat, to treat smallpox. The treatment is being reviewed by the U.S. Food and Drug Administration for approval.